BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Holtmann G, Bigard MA, Malfertheiner P, Pounder R. Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD. Int J Clin Pharm. 2011;33:493-500. [PMID: 21472476 DOI: 10.1007/s11096-011-9489-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Alhossan A, Alrabiah Z, Alghadeer S, Bablghaith S, Wajid S, Al-Arifi M. Attitude and knowledge of Saudi community pharmacists towards use of proton pump inhibitors. Saudi Pharm J 2019;27:225-8. [PMID: 30766433 DOI: 10.1016/j.jsps.2018.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lin CW, Li XR. Surgical treatment of gastroesophageal reflux disease. Shijie Huaren Xiaohua Zazhi 2015; 23(32): 5093-5100 [DOI: 10.11569/wcjd.v23.i32.5093] [Reference Citation Analysis]
3 Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011. JAMA Intern Med 2016;176:473-82. [PMID: 26998708 DOI: 10.1001/jamainternmed.2015.8581] [Cited by in Crossref: 275] [Cited by in F6Publishing: 216] [Article Influence: 45.8] [Reference Citation Analysis]
4 MacFarlane B. Management of gastroesophageal reflux disease in adults: a pharmacist's perspective. Integr Pharm Res Pract 2018;7:41-52. [PMID: 29892570 DOI: 10.2147/IPRP.S142932] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Scarpignato C, Tolone S. Addressing long-term PPI safety. Digestive and Liver Disease 2020;52:853-6. [DOI: 10.1016/j.dld.2020.05.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 MacFarlane B, Matthews A, Bergin J. Non-prescription treatment of NSAID induced GORD by Australian pharmacies: a national simulated patient study. Int J Clin Pharm 2015;37:851-6. [PMID: 25972205 DOI: 10.1007/s11096-015-0129-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
7 Scarpignato C, Gatta L, Zullo A, Blandizzi C; SIF-AIGO-FIMMG Group; Italian Society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of General Practitioners. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14:179. [PMID: 27825371 DOI: 10.1186/s12916-016-0718-z] [Cited by in Crossref: 148] [Cited by in F6Publishing: 123] [Article Influence: 24.7] [Reference Citation Analysis]
8 Zou JB, Zhang XF, Shi YJ, Tai J, Wang Y, Liang YL, Wang F, Cheng JX, Wang J, Guo DY. Therapeutic Efficacy of Kangfuxin Liquid Combined with PPIs in Gastric Ulcer. Evid Based Complement Alternat Med 2019;2019:1324969. [PMID: 31662770 DOI: 10.1155/2019/1324969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Keber E, Rocco P, Musazzi UM, Morselli-labate AM, Floris NP, Pedrazzini A, Minghetti P, Giua C. The management of upper gastrointestinal symptoms: A study on community pharmacies in Italy. PHAR 2021;68:401-9. [DOI: 10.3897/pharmacia.68.e66065] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Johnson DA, Katz PO, Armstrong D, Cohen H, Delaney BC, Howden CW, Katelaris P, Tutuian RI, Castell DO. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. Drugs 2017;77:547-61. [PMID: 28233274 DOI: 10.1007/s40265-017-0712-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
11 Boardman HF, Heeley G. The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors. Int J Clin Pharm 2015;37:709-16. [PMID: 26100836 DOI: 10.1007/s11096-015-0150-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
12 da Rocha CE, Lessa FAS, Venceslau DO, Sakuraba CS, Barros IMC, de Lyra DP. Development of a decision support system for the practice of responsible self-medication. Int J Clin Pharm 2016;38:152-61. [DOI: 10.1007/s11096-015-0223-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]